Home Careers Contact

Price: 4.55

Change: 0.00

Day High: 4.69
Day Low: 4.35
Volume: 2,419,359

4:00 PM ET | Jun 23, 2017
Delayed 20 min., by eSignal.



Shareholder Tools

Press Releases

Company News
View Summary Eight Presentations at ASM Microbe Include Late Breaker From Cempra's Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media
Jun 2, 2017
PDF 19.3 KB Add to Briefcase
View Summary Cempra to Present at the Jefferies 2017 Global Healthcare Conference
Jun 2, 2017
PDF 13.7 KB Add to Briefcase
View Summary Cempra Presents Data on Ophthalmic Solithromycin at ARVO
May 10, 2017
PDF 16.3 KB Add to Briefcase
View Summary Cempra Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 28, 2017
PDF 25.8 KB Add to Briefcase
View Summary Cempra Presents Data at ECCMID Highlighting Need for New CABP Therapies and Activity of Solithromycin in Key Population Groups
Apr 21, 2017
PDF 18.9 KB Add to Briefcase
View Summary Cempra to Report First Quarter 2017 Financial Results
Apr 13, 2017
PDF 13.8 KB Add to Briefcase
View Summary Cempra to Present at the 16th Annual Needham & Company Healthcare Conference
Mar 29, 2017
PDF 13.6 KB Add to Briefcase
View Summary Cempra Withdraws Solithromycin Marketing Authorization Application in Europe
Mar 28, 2017
PDF 15.5 KB Add to Briefcase
View Summary Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options
Mar 13, 2017
PDF 15.8 KB Add to Briefcase
View Summary Cempra to Present at 29th Annual ROTH Conference
Mar 3, 2017
PDF 15.3 KB Add to Briefcase
Showing 1-10 of 234 Page: 1 2 3 4 5 ... 24  Next 10
Add to Briefcase = add release to Briefcase